Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous vitamin B6 for prevention of chemotherapy-induced nausea and vomiting in pediatric patients
IRCT20150119020715N8Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pyridoxine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Arak University of Medical Sciences. Started Apr 2017; status: completed.
02
Drugs
pyridoxine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on IRCT20150119020715N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150119020715N8.